Assignee
THE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION
US·31 granted patents·4 pending applications·64 citations·filing 2014–2024
Top patents by PatentIndex Score
35 records- 0194US10028995B2Angiotensin II alone or in combination for the treatment of hypotensionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2015·Granted Jul 24, 2018·11 cites·40 claims
- 0294US9867863B2Method of treating low blood pressureTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION·Filed 2016·Granted Jan 16, 2018·12 cites·28 claims
- 0393US10335451B2Method of treating low blood pressureTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2018·Granted Jul 2, 2019·8 cites·26 claims
- 0493US10322160B2Method of treating low blood pressureTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2018·Granted Jun 18, 2019·8 cites·29 claims
- 0588US12024493B2Isoxazole hydroxamic acids as histone deacetylase 6 inhibitorsTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2022·Granted Jul 2, 2024·1 cites·15 claims
- 0688US10548943B2Method of treating low blood pressureTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2019·Granted Feb 4, 2020·3 cites·26 claims
- 0787US10765722B2Angiotensin II alone or in combination for the treatment of hypotensionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2018·Granted Sep 8, 2020·3 cites·10 claims
- 0887US10500247B2Method of treating low blood pressureTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2018·Granted Dec 10, 2019·3 cites·22 claims
- 0987US10493124B2Angiotensin II alone or in combination for the treatment of hypotensionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2018·Granted Dec 3, 2019·3 cites·30 claims
- 1086US11066706B2Blood biomarkers for appendicitis and diagnostics methods using biomarkersTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2015·Granted Jul 20, 2021·2 cites·11 claims
- 1185US11096983B2Angiotensin II alone or in combination for the treatment of hypotensionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2019·Granted Aug 24, 2021·2 cites·27 claims
- 1284US2023226141A1Angiotensin ii alone or in combination for the treatment of hypotensionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2023·Application pending·0 cites
- 1380US12522572B2Isoxazole hydroxamic acids as histone deacetylase 6 inhibitorsTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2024·Granted Jan 13, 2026·0 cites·19 claims
- 1480US11559559B2Angiotensin II alone or in combination for the treatment of hypotensionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2021·Granted Jan 24, 2023·0 cites·13 claims
- 1579US10383979B2Myocyte-derived flow assist device: extravasal sheaths of rhythmically contracting myocytes aiding flow of biological fluidsTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2014·Granted Aug 20, 2019·2 cites·13 claims
- 1679US2020376073A1Method of treating low blood pressureTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2019·Application pending·0 cites
- 1777US11472780B2Isoxazole hydroxamic acids as histone deacetylase 6 inhibitorsTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2018·Granted Oct 18, 2022·1 cites·8 claims
- 1874US10851418B2Blood biomarkers for respiratory infectionsTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2016·Granted Dec 1, 2020·1 cites·19 claims
- 1974US10688223B2Smart release system for growth factor delivery and combined bone and vascular growthTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2017·Granted Jun 23, 2020·3 cites·8 claims
- 2068US11629383B2Blood biomarkers for respiratory infectionsTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2020·Granted Apr 18, 2023·0 cites·10 claims
- 2168US11561217B2Compounds inhibiting Nef-calnexin interactionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2021·Granted Jan 24, 2023·0 cites·9 claims
- 2267US11596715B2Myocyte-derived flow assist device: extravasal sheaths of rhythmically contracting myocytes aiding flow of biological fluidsTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2019·Granted Mar 7, 2023·0 cites·15 claims
- 2363US11371096B2Blood biomarkers for appendicitis and diagnostics methods using biomarkersTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2015·Granted Jun 28, 2022·0 cites·3 claims
- 2462US11131661B2Compounds inhibiting Nef-calnexin interactionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2020·Granted Sep 28, 2021·0 cites·9 claims
- 2559US10684274B2Compounds inhibiting Nef-calnexin interactionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2017·Granted Jun 16, 2020·0 cites·1 claims
- 2657US10272056B2Treatment for mitochondrial diseasesTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2016·Granted Apr 30, 2019·1 cites·9 claims
- 2753US12122799B2Antibiotics for veterinary staphylococcal infectionsTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2019·Granted Oct 22, 2024·0 cites·5 claims
- 2853US11160767B24,4′-trans-dihydroxystilbene for use in treating cancerTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2018·Granted Nov 2, 2021·0 cites·19 claims
- 2951US10406261B2Biomimetic biphasic 3D nanocomposite scaffold for osteochondral regenerationTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2015·Granted Sep 10, 2019·0 cites·14 claims
- 3049US2023416739A1B-spectrin (sptbn1) deficiency protects mice from high-fat diet-induced liver disease and cancer developmentTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2021·Application pending·0 cites
- 3148US12344826B2Apparatus and methods for in vitro preclinical human trialsTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2018·Granted Jul 1, 2025·0 cites·14 claims
- 3247US2023405118A1Stat-activated macrophages, compositions, and uses thereofTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2021·Application pending·0 cites
- 3346US12485174B2HDAC6-activated macrophages, compositions, and uses thereofTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2020·Granted Dec 2, 2025·0 cites·10 claims
- 3442US11400185B2Biocompatible smart biomaterials with tunable shape changing and enhanced cytocompatibility propertiesTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2016·Granted Aug 2, 2022·0 cites·8 claims
- 3539US10813941B2Methods and compounds for treating malariaTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2017·Granted Oct 27, 2020·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when THE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →